Cleansing Notice
Released
Released
Announcement PDF
13 March 2020
Company Announcements Office
Australian Securities Exchange
20 Bridge Street
SYDNEY NSW 2000
Dear Sir/Madam
NOTICE UNDER SECTION 708A OF THE CORPORATIONS ACT
This notice is given by Race Oncology Limited pursuant to section 708A(5)(e) of the Corporations
Act (Act).
The Company has today issued 347,561 fully paid ordinary shares at an issue price of $0.10 per
share (Issued Shares) following the exercise of 500,000 unlisted 12 March 2024 employee options
with an exercise price of $0.10 (Options). The 500,000 Options were exercised on a cashless
exercise basis, resulting in the issue of 347,561 shares at a ‘market price’ of $0.328 per share.
Pursuant to section 708A(5)(e) of the Act, the Company gives notice that:
1. the Issued Shares were issued without disclosure to investors under part 6D.2 of the Act;
2. as at the date of this notice, the Company has complied with:
(a) the provisions of Chapter 2M of the Act as they apply to the Company; and
(b) section 674 of the Act; and
3. as at the date of this notice, there is no information that is “excluded information” (as defined
in section 708A(7) of the Act) which is required to be disclosed by the Company.
Yours faithfully
Peter Webse
Company Secretary
Race Oncology Ltd ABN 61 149 318 749
Registered office: L40, 140 William St, Melbourne VIC Australia 3000
www.raceoncology.com
Share your feedback
Discover